AAAAAA

   
Results: 1-9 |
Results: 9
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial
Authors: Khuri, FR Kim, ES Lee, JJ Winn, RJ Benner, SE Lippman, SM Fu, KK Cooper, JS Vokes, EE Chamberlain, RM Williams, B Pajak, TF Goepfert, H Hong, WK
Citation: Fr. Khuri et al., The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial, CANC EPID B, 10(8), 2001, pp. 823-829
Validation of the RTOG recursive partitioning classification for head and neck tumors
Authors: Cooper, JS Berkey, B Marcial, V Fu, KK Lee, DJ
Citation: Js. Cooper et al., Validation of the RTOG recursive partitioning classification for head and neck tumors, HEAD NECK, 23(8), 2001, pp. 669-677
Comparison of two equivalency factor approaches with simplified risk assessment for LCIA of toxicity impact potential
Authors: Tolle, DA Hesse, DJ Chadwell, GB Cooper, JS Evers, DP
Citation: Da. Tolle et al., Comparison of two equivalency factor approaches with simplified risk assessment for LCIA of toxicity impact potential, INT J LIFE, 6(2), 2001, pp. 96-105
Concurrent chemotherapy and radiation therapy for advanced stage carcinomaof the nasopharynx
Authors: Cooper, JS
Citation: Js. Cooper, Concurrent chemotherapy and radiation therapy for advanced stage carcinomaof the nasopharynx, INT J RAD O, 48(5), 2000, pp. 1277-1279
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
Authors: Fu, KK Pajak, TF Trotti, A Jones, CU Spencer, SA Phillips, TL Garden, AS Ridge, JA Cooper, JS Ang, KK
Citation: Kk. Fu et al., A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003, INT J RAD O, 48(1), 2000, pp. 7-16
Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience
Authors: Cooper, JS Lee, H Torrey, M Hochster, H
Citation: Js. Cooper et al., Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience, INT J RAD O, 47(4), 2000, pp. 861-866
Effect of combined adoptive immunotherapy and radiotherapy on tumor growth
Authors: Sumareva, R Ukrainsky, G Kiremidjian-Schumacher, L Roy, M Wishe, HI Steinfeld, AD Cooper, JS
Citation: R. Sumareva et al., Effect of combined adoptive immunotherapy and radiotherapy on tumor growth, RADIAT ON I, 7(1), 1999, pp. 22-29
Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
Authors: Cooper, JS Guo, MD Herskovic, A Macdonald, JS Martenson, JA Al-Sarraf, M Byhardt, R Russell, AH Beitler, JJ Spencer, S Asbell, SO Graham, MV Leichman, LL
Citation: Js. Cooper et al., Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01), J AM MED A, 281(17), 1999, pp. 1623-1627
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
Authors: Lee, WR Berkey, B Marcial, V Fu, KK Cooper, JS Vikram, B Coia, LR Rotman, M Ortiz, H
Citation: Wr. Lee et al., Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27, INT J RAD O, 42(5), 1998, pp. 1069-1075
Risultati: 1-9 |